These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25178645)
1. Psoriasis and skin pain: instrumental and biological evaluations. Patruno C; Napolitano M; Balato N; Ayala F; Megna M; Patrì A; Cirillo T; Balato A Acta Derm Venereol; 2015 Apr; 95(4):432-8. PubMed ID: 25178645 [TBL] [Abstract][Full Text] [Related]
2. Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics. Ljosaa TM; Rustoen T; Mörk C; Stubhaug A; Miaskowski C; Paul SM; Wahl AK Acta Derm Venereol; 2010; 90(1):39-45. PubMed ID: 20107724 [TBL] [Abstract][Full Text] [Related]
3. Perfusion Intensity Correlates with Expression Levels of Psoriasis-Related Genes and Proteins. Hendriks AG; Steenbergen W; Zeeuwen PL; Schalkwijk J; Hondebrink E; Klitsie MA; Schreurs R; van de Kerkhof PC; Seyger MM Skin Pharmacol Physiol; 2015; 28(6):296-306. PubMed ID: 26361329 [TBL] [Abstract][Full Text] [Related]
4. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610 [TBL] [Abstract][Full Text] [Related]
5. Association of disease severity with IL-1 levels in methotrexate-treated psoriasis patients. Tamilselvi E; Haripriya D; Hemamalini M; Pushpa G; Swapna S Scand J Immunol; 2013 Dec; 78(6):545-53. PubMed ID: 24283773 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive skin biomarkers quantification of psoriasis and atopic dermatitis: cytokines, antioxidants and psoriatic skin auto-fluorescence. Portugal-Cohen M; Horev L; Ruffer C; Schlippe G; Voss W; Ma'or Z; Oron M; Soroka Y; Frušić-Zlotkin M; Milner Y; Kohen R Biomed Pharmacother; 2012 Jun; 66(4):293-9. PubMed ID: 22397760 [TBL] [Abstract][Full Text] [Related]
7. The role of interleukin-12 in the pathogenesis of psoriasis. Shaker OG; Moustafa W; Essmat S; Abdel-Halim M; El-Komy M Clin Biochem; 2006 Feb; 39(2):119-25. PubMed ID: 16386240 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401 [TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis of the corticotrophin-releasing hormone-proopiomelanocortin system in psoriasis skin biopsies. Loite U; Kingo K; Reimann E; Reemann P; Vasar E; Silm H; Kõks S Acta Derm Venereol; 2013 Jul; 93(4):400-5. PubMed ID: 23303587 [TBL] [Abstract][Full Text] [Related]
10. Localization of touch versus heat pain in the human hand: a dissociative effect of temporal parameters on discriminative capacity and decision strategy. Ylioja S; Carlson S; Raij TT; Pertovaara A Pain; 2006 Mar; 121(1-2):6-13. PubMed ID: 16480826 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1: a key inflammatory mediator in psoriasis? Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions. Liu R; Yang Y; Yan X; Zhang K Eur J Dermatol; 2013; 23(5):600-7. PubMed ID: 24135516 [TBL] [Abstract][Full Text] [Related]
13. Prolactin level is significantly elevated in lesional skin of patients with psoriasis. El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663 [TBL] [Abstract][Full Text] [Related]
14. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708 [TBL] [Abstract][Full Text] [Related]
17. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299 [TBL] [Abstract][Full Text] [Related]
18. Proteolytic activity and expression of the 20S proteasome are increased in psoriasis lesional skin. Henry L; Le Gallic L; Garcin G; Coux O; Jumez N; Roger P; Lavabre-Bertrand T; Martinez J; Meunier L; Stoebner PE Br J Dermatol; 2011 Aug; 165(2):311-20. PubMed ID: 21740404 [TBL] [Abstract][Full Text] [Related]
19. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument. Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000 [TBL] [Abstract][Full Text] [Related]
20. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]